Advisory Board

Dr. Brad Thompson

Brad Thompson, Ph.D. is Chairman, CEO, & CTO at Wyvern Pharmaceuticals.
Brad is an experienced biotechnology company founder and company executive, currently CEO at Kickshaw Ventures and Wyvern Pharmaceuticals, and formerly CEO of Oncolytics Biotech, from 1999 to 2016 and CEO of Synsorb Biotech from 1994 to 1999.
He has served as Chairman, Director and Audit Committee member on a number of other public company (NASDAQ, TSX, CDNX) boards of directors, and private company boards and industry groups (including Chairman and Chairman Emeritus of BIOTECanada).
Brad earned his BSc in Microbiology in the University of Alberta in 1978 and his Ph.D. from the University of Western Ontario in the Department of Microbiology and Immunology in 1981.
Read his LinkedIn profile.